OncoZenge AB (publ) (STO:ONCOZ)

OncoZenge AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.71	3.86	12.63	29.14	51.22
Cash & Short-Term Investments	3.71	3.86	12.63	29.14	51.22
Cash Growth	-3.86%	-69.41%	-56.67%	-43.11%	412.23%
Other Receivables	2.54	0.52	0.64	0.71	0.85
Receivables	2.54	0.52	0.64	0.71	0.85
Prepaid Expenses	2.23	0.2	0.22	0.19	0.06
Total Current Assets	8.49	4.58	13.49	30.04	52.13
Other Intangible Assets	6.85	6.85	6.85	6.85	6.85
Long-Term Deferred Tax Assets	-	-	-	-	3.08
Long-Term Deferred Charges	-	-	-	-	23.17
Other Long-Term Assets	9.06	-	-	-	-
Total Assets	24.4	11.43	20.34	36.89	85.23
Accounts Payable	6.8	0.66	0.93	1.65	4.02
Accrued Expenses	1.55	0.78	0.66	1.01	0.5
Other Current Liabilities	0.07	0.05	0.11	0.26	0.39
Total Current Liabilities	8.42	1.48	1.7	2.92	4.9
Long-Term Debt	7.5	-	-	-	-
Total Liabilities	15.92	1.48	1.7	2.92	4.9
Common Stock	1.41	1.3	1.3	1.3	1.3
Additional Paid-In Capital	98.77	84.41	84.41	83.84	83.54
Retained Earnings	-91.7	-75.76	-67.07	-51.17	-4.52
Shareholders' Equity	8.48	9.95	18.64	33.97	80.32
Total Liabilities & Equity	24.4	11.43	20.34	36.89	85.23
Total Debt	7.5	-	-	-	-
Net Cash (Debt)	-3.79	3.86	12.63	29.14	51.22
Net Cash Growth	-	-69.41%	-56.67%	-43.11%	412.23%
Net Cash Per Share	-0.30	0.33	1.08	2.49	4.35
Filing Date Shares Outstanding	12.65	11.71	11.71	11.71	11.71
Total Common Shares Outstanding	12.65	11.71	11.71	11.71	11.71
Working Capital	0.06	3.1	11.79	27.12	47.23
Book Value Per Share	0.67	0.85	1.59	2.90	6.86
Tangible Book Value	1.63	3.1	11.79	27.12	73.47
Tangible Book Value Per Share	0.13	0.26	1.01	2.32	6.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.